Study Examines Treatment Retention Among HIV Patients in Uganda
August 8, 2013
The Center for Global Health Policy's "Science Speaks" blog reports on a study, released this week by Clinical Infectious Diseases, that "follow[ed] patients in two Ugandan HIV care centers (one rural, one urban), [and] found not only were retention rates high for patients still considered too healthy to be eligible for medicine under guidelines of the last few years, but concluded those retention rates may be 'systematically underestimated in many other settings.'" According to the blog, "The findings carry weight against a long unchallenged perception that people who feel well drop out of treatment, the resulting conclusion that patients receiving medicine before they have begun to feel ill can't be counted on to continue to take it, and the specter that is then raised -- that early treatment could lead to widespread drug resistance" (Barton, 8/7).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)